Insider trades
Thomas Trimarchi, CFO of BridgeBio Pharma BBIO, has filed 0 purchases and 9 sales on the open market. Over the past 12 months that comes to a net sale of $3M. The latest trade was on 05/18.
Thomas Trimarchi
President and CFO
- Company
- BridgeBio Pharma BBIO
- First filing
- 24/08/08
- Trades
- 23 trades
- Buys / sales
- 0 / 9
- 12-month net buying
- −$3M
- Last trade
- 05/18
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
BBIO | Open-market sale10b5-1 plan | 05/18 | 05/19 | 13,651 sh2 trades | $65.08avg. | $888,468.17 | −3.7% |
BBIO | Open-market sale10b5-1 plan | 02/17 | 02/18 | 13,600 sh2 trades | $74.72avg. | $1,016,190 | −3.9% |
BBIO | Open-market sale10b5-1 plan | 25/11/17 | 25/11/18 | 16,934 sh2 trades | $66.46avg. | $1,125,382.86 | −4.2% |
BridgeBio PharmaBBIO | Open-market sale | 25/08/21 | 25/08/22 | 42,237 sh | $49.48 | $2,089,886.76 | −9.1% |
BBIO | Open-market sale10b5-1 plan | 25/08/18 | 25/08/19 | 17,353 sh2 trades | $50.23avg. | $871,657.82 | −3.6% |